Results for tag: "Microalbuminuria Drug"

The Microalbuminuria Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat microalbuminuria, a condition in which small amounts of albumin are present in the urine. These drugs are used to reduce the risk of kidney damage and other complications associated with the condition. Commonly prescribed drugs include ACE inhibitors, angiotensin receptor blockers, diuretics, and calcium channel blockers. These drugs work by reducing the amount of albumin in the urine, thereby reducing the risk of kidney damage. The Microalbuminuria Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. These companies are constantly innovating and developing new drugs to meet the needs of patients with microalbuminuria. Show Less Read more